Biotech Winners 2015: Rayno Mid Caps Were Up 29.6%
January 03, 2016 at 22:00 PM EST
We previously reviewed the Rayno Small Cap Portfolio which was up 38.1% in Q4 2015 and the Mid-Caps also beat despite a big loss by Clovis Oncology after the FDA required more data on its lung cancer drug.